The coronavirus (COVID-19) pandemic has increased in patients requiring intensive care around the world. Many critically ill patients with severe respiratory distress syndrome caused by SARS-CoV2 infection develop acute kidney injury (AKI) and require renal replacement therapy (RRT), putting RRT delivery capacity in disease outbreak at risk. Furthermore, despite the administration of systemic anticoagulation, the…